🚀 VC round data is live in beta, check it out!
Shiseido Valuation Multiples
Discover revenue and EBITDA valuation multiples for Shiseido and similar public comparables like Dabur India, Colgate-Palmolive (India), Mankind Pharma, Bausch + Lomb and more.
Shiseido Overview
About Shiseido
Shiseido is a leading Japanese cosmetics manufacturer focused in the prestige and premium categories. Founded in 1872, it was the first Western-style pharmacy in Ginza, Tokyo, and is one of the oldest cosmetics companies globally. Shiseido’s suite of 31 brands, which include its namesake brand, Clé de Peau Beauté, and NARS, had a 10.2% share of Japan’s beauty and personal care market in 2024 according to Euromonitor. It is also ranked in the top 4-5 globally, with around 7% to 8% market share in premium and prestige color cosmetics and skincare. In terms of revenue, Japan and China, which include travel retail, are the two key markets making up 65% of group revenue in 2025.
Founded
1927
HQ
Employees
33.0K
Website
Sectors
Financials (LTM)
EV
$9B
Shiseido Financials
Shiseido reported last 12-month revenue of $6B and EBITDA of $716M.
In the same LTM period, Shiseido generated $5B in gross profit, $716M in EBITDA, and had net loss of ($109M).
Revenue (LTM)
Shiseido P&L
In the most recent fiscal year, Shiseido reported revenue of $6B and EBITDA of $678M.
Shiseido expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $6B | XXX | $6B | XXX | XXX | XXX |
| Gross Profit | $5B | XXX | $5B | XXX | XXX | XXX |
| Gross Margin | 77% | XXX | 74% | XXX | XXX | XXX |
| EBITDA | $716M | XXX | $678M | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 11% | XXX | XXX | XXX |
| EBIT Margin | 5% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | ($109M) | XXX | ($256M) | XXX | XXX | XXX |
| Net Margin | (2%) | XXX | (4%) | XXX | XXX | XXX |
| Net Debt | — | — | $755M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Shiseido Stock Performance
Shiseido has current market cap of $8B, and enterprise value of $9B.
Market Cap Evolution
Shiseido's stock price is $19.59.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $9B | $8B | 0.3% | XXX | XXX | XXX | $-0.64 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialShiseido Valuation Multiples
Shiseido trades at 1.4x EV/Revenue multiple, and 12.7x EV/EBITDA.
EV / Revenue (LTM)
Shiseido Financial Valuation Multiples
As of April 19, 2026, Shiseido has market cap of $8B and EV of $9B.
Equity research analysts estimate Shiseido's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Shiseido has a P/E ratio of (72.0x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $8B | XXX | $8B | XXX | XXX | XXX |
| EV (current) | $9B | XXX | $9B | XXX | XXX | XXX |
| EV/Revenue | 1.4x | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | 12.7x | XXX | 13.4x | XXX | XXX | XXX |
| EV/EBIT | 27.9x | XXX | 31.4x | XXX | XXX | XXX |
| EV/Gross Profit | 1.9x | XXX | 1.9x | XXX | XXX | XXX |
| P/E | (72.0x) | XXX | (30.5x) | XXX | XXX | XXX |
| EV/FCF | 33.9x | XXX | 22.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Shiseido Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Shiseido Margins & Growth Rates
Shiseido's revenue in the last 12 month grew by 1%.
Shiseido's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Shiseido's rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Shiseido's rule of X is 22% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Shiseido Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | 1% | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Growth | 16% | XXX | 19% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 17% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 22% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 29% | XXX | 29% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 72% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 4% | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 77% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Shiseido Public Comps
See public comps and valuation multiples for other Health & Beauty comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Shiseido | XXX | XXX | XXX | XXX | XXX | XXX |
| Dabur India | XXX | XXX | XXX | XXX | XXX | XXX |
| Colgate-Palmolive (India) | XXX | XXX | XXX | XXX | XXX | XXX |
| Mankind Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Bausch + Lomb | XXX | XXX | XXX | XXX | XXX | XXX |
| Lenskart | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Shiseido M&A Activity
Shiseido acquired XXX companies to date.
Last acquisition by Shiseido was on XXXXXXXX, XXXXX. Shiseido acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Shiseido
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialShiseido Investment Activity
Shiseido invested in XXX companies to date.
Shiseido made its latest investment on XXXXXXXX, XXXXX. Shiseido invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Shiseido
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Shiseido
| When was Shiseido founded? | Shiseido was founded in 1927. |
| Where is Shiseido headquartered? | Shiseido is headquartered in Japan. |
| How many employees does Shiseido have? | As of today, Shiseido has over 33K employees. |
| Who is the CEO of Shiseido? | Shiseido's CEO is Kentaro Fujiwara. |
| Is Shiseido publicly listed? | Yes, Shiseido is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Shiseido? | Shiseido trades under 4911 ticker. |
| When did Shiseido go public? | Shiseido went public in 1949. |
| Who are competitors of Shiseido? | Shiseido main competitors are Dabur India, Colgate-Palmolive (India), Mankind Pharma, Bausch + Lomb. |
| What is the current market cap of Shiseido? | Shiseido's current market cap is $8B. |
| What is the current revenue of Shiseido? | Shiseido's last 12 months revenue is $6B. |
| What is the current revenue growth of Shiseido? | Shiseido revenue growth (NTM/LTM) is 1%. |
| What is the current EV/Revenue multiple of Shiseido? | Current revenue multiple of Shiseido is 1.4x. |
| Is Shiseido profitable? | Yes, Shiseido is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Shiseido? | Shiseido's last 12 months EBITDA is $716M. |
| What is Shiseido's EBITDA margin? | Shiseido's last 12 months EBITDA margin is 11%. |
| What is the current EV/EBITDA multiple of Shiseido? | Current EBITDA multiple of Shiseido is 12.7x. |
| What is the current FCF of Shiseido? | Shiseido's last 12 months FCF is $268M. |
| What is Shiseido's FCF margin? | Shiseido's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of Shiseido? | Current FCF multiple of Shiseido is 33.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.